Changes in the function and ultrastructure of vessels in the rat model of multiple low dose streptozotocin-induced diabetes

General Physiology and Biophysics

Volumn 25, Issue 3, 2006, Pages 289-302

  Sotnikova, Ruzena ^a   Skalska, S ^a   Okruhlicova, L ^b   Navarova, J ^a   Kyselova, Z ^a   Zurova, J ^a   Stefek, M ^a   Hozova, R ^c   Nosalova, V ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

^c Drug Research Institute   (Slovakia)

Author keywords

Antioxidant stobadine; Endothelium; Femoral artery; Mesenteric artery; Rat multiple low dose STZ diabetes

Indexed keywords

ANTIOXIDANT; CARBOLINE DERIVATIVE; GLUCOSE; N ACETYL BETA GLUCOSAMINIDASE; REACTIVE OXYGEN METABOLITE; STOBADINE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; BLOOD VESSEL FUNCTION; BOLUS INJECTION; BULIMIA; CAPILLARY; CONTROLLED STUDY; ENDOTHELIUM INJURY; ENZYME BLOOD LEVEL; EXPERIMENTAL DIABETES MELLITUS; FEMORAL ARTERY; GLUCOSE BLOOD LEVEL; LOW DRUG DOSE; MALE; MESENTERIC ARTERY; MESENTERY BLOOD VESSEL; NONHUMAN; OXIDATIVE STRESS; POLYDIPSIA; POLYURIA; RAT; STREPTOZOCIN DIABETES; ULTRASTRUCTURE; VASCULAR ENDOTHELIUM; WEIGHT GAIN;

ANIMALS; ANTIOXIDANTS; BLOOD VESSELS; CARBOLINES; DIABETES MELLITUS, EXPERIMENTAL; FEMORAL ARTERY; MALE; MESENTERIC ARTERIES; MICROSCOPY, ELECTRON; OXIDATIVE STRESS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; STREPTOZOCIN; VASODILATION;

ANIMALIA;

EID: 33845234511     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Altan V. M., Karasu Ç., Özüiari A. (1989): The effects of type-1 and type-2 diabetes on endothelium-dependent relaxation in rat aorta. Pharmacol. Biochem. Behav. 33, 519-522
2. Barrett A. J., Heath M. F. (1977): Lysosomal enzymes. In: Lysosomes: A Laboratory Handbook (Ed. J. T. Dingle), 2nd ed., pp. 19-145, Elsevier/ North-Holland Biomedical Press, Amsterdam
3. Baynes J. W., Thorne S. (1999): Role of oxidative stress in diabetic complications: a new perspectives on an old paradigm. Diabetes 48, 1-9
4. Frank P. G., Woodman S. E., Park D. S., Lisanti M. P. (2003): Caveolin, caveolae, and edothelial cell function. Arterioscler. Thromb. Vasc. Biol. 23, 1161-1168
5. Gajdošík A., Gajdošíková A., Štefek M., Navarová J., Hozová R. (1999): Streptozotocin-induced experimental diabetes in male Wistar rats. Gen. Physiol. Biophys. 18 (Focus Issue), 54-62
6. Gajdosikova A., Ujhazy E., Gajdosik A., Chalupa I., Blasko M., Tomaskova A., Liska J., Dubovicky M., Bauer V. (1995): Chronic toxicity and micronucleus assay of the new cardioprotective agent stobadine in rats. Arzneimittelforschung 45, 531-536
7. Gugliucci A. (2000): Glycation as the glucose link to diabetic complication. J. Am. Osteopath. Assoc. 100, 621-634
8. Guzik T. J., Mussa S., Gastaldi D., Sadowski J., Ratnatunga C., Pillai R., Channon K. M. (2002): Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 105, 1656-1662
9. Horakova L., Stolc S. (1998): Antioxidant and pharmacodynamic effects of pyridoindole stobadine. Gen. Pharmacol. 30, 627-638
10. Hrabak A., Szabo A., Bajor T., Korner A. (2006): Differences in the nitric oxide metabolism in streptozotocin-treated rats and children suffering from Type 1 diabetes. Life Sci. 78, 1362-1370
11. Irat A. M., Aktan F., Ozansoy G. (2003): Effects of L-carnitine treatment on oxidant/anti-oxidant state and vascular reactivity of streptozotocin-diabetic rat aorta. J. Pharm. Pharmacol. 55, 1389-1395
12. Kallay Z., Bittererova, J., Brejcha A., Faberova V., Bezek S., Trnovec T. (1990): Plasma concentration, tissue distribution and excretion of the prospective cardioprotective agent cis- (-)-2,3,4,,4a,5,9b-hexahydro-2,8-dimethyl-IH-pyrido- [4,3-b] indole dihydrochloride in rats. Arzneimittelforschung 40, 974-979
13. Kamata K., Miyata N., Kasoya Y. (1989): Impairement of endothelium-dependent relaxation and changes in levels of cyclic GMP in aorta from streptozotocin-induced. diabetic rats. Br. J. Pharmacol. 97, 614-618
14. Karasu Ç., Avci A., Canbolat O., Bali M., Ozansoy G., Ceylan A., Ari N., Stefek M. (2002): Comparative effect of stobadine and vitamin E treatments on oxidative stress markers in heart and kidney of streptozotocin-diabetic rats. Free Radic. Biol. Med. 33, S188
15. Kinoshita J. H. (1990): A thirty year journey in the polyol pathway. Exp. Eye Res. 50, 567-573
16. Kyselova Z., Gajdosik A., Gajdosikova A., Ulicna O., Mihalova D., Karasu Ç., Stefek M. (2005): Effect of the pyridoindole antioxidant stobadine on development of experimental diabetic cataract and on lens protein oxidation in rats: comparison with vitamin E and BHT. Mol. Vis. 19, 56-65
17. Konukoglu D., Akcay T., Dincer Y., Hatemi H. (1999): The susceptibility of red blood cells to autoxidation in type 2 diabetic patients with angiopathy. Metab., Clin. Exp. 48, 1481-1484
18. Landmesser U., Harrison D. G., Drexler H. (2005): Oxidant stress - a major cause of reduced endothelial nitric oxide availability in cardiovascular disease. Eur. J. Clin. Pharmacol. 12, 1-7
19. Okruhlicova L., Tribulova N., Weismann P., Sotnikova R. (2005): Ultrastructure and histochernistry of rat myocardial capillary endothelial cells in response to diabetes and hypertension. Cell Res. 15, 532-538
20. 2+-ATPase activity in heart and liver of streptozotocin-diabetic rats: comparison with vitamin E. Biochim. Biophys. Acta 1588, 71-78
21. Sotnikova R., Okruhlicova L., Navarova J., Stefek M., Gajdosik A., Gajdosikova A. (2000): Toxic effect of hyperglycemia on rat aortic function and structure: effect of L-arginine. Biologia 55 (Suppl. 8), 107-111
22. Sotnikova R., Stefek M., Okruhlicova L., Navarova J., Bauer V., Gajdosik A., Gajdosikova A. (2001): Dietary supplementation of the pyridoindole antioxidant stobadine reduces vascular impairement in streptozotocin-diabetic rats. Meth. Find. Exp. Clin. Pharmacol. 23, 121-129
23. Stefek M., Benes L., Jergelova M., Scasnar V., Turi-Nagy L., Kocis P. (1987): Biotransformation of stobadine, a garnma-carboline antiarrhythmic and cardioprotective agent, in rat liver microsomes. Xenobiotica 17, 1067-1073
24. Stefek M., Benes L., Zelnik V. (1989): N-oxygenation of stobadine, a gamma-carboline antiarrhythmic and cardioprotective agent: the role of flavin-containing monooxy-genase. Xenobiotica 19, 143-150
25. Stefek M., Sotnikova R., Okruhlicova L., Volkovova K., Kucharska J., Gajdosik A., Gajdosikova A., Mihalova D., Hozova R., Tribulova N., Gvozdjakova A. (2000): Effect of dietary supplementation with the pyridoindole antioxidant stobadine on an-tioxidant state and ultrastructure of diabetic rat myocardium. Acta Diabetol. 37, 111-117
26. Stefek M., Gajdosik A., Tribulova N., Navarova J., Volkovova K., Weismann P., Gajdosikova A., Drimal J., Mihalova D. (2002): The pyridoindole antioxidant stobadine attenuates albuminuria, enzymuria, kidney lipid peroxidation and matrix collagen cross-linking in streptozotocin-induced diabetic rats. Methods Find. Exp. Clin. Pharmacol. 24, 565-571
27. Taha S. A., Raza M. (1996): Protection by epicoprostanol against hyperglycemia and insulitis in normal and diabetic rats. J. Ethnopharmacol. 50, 85-90
28. Tietze F. (1969): Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 27, 502-522
29. Uehara Y., Hirawa N., Kawabata Y., Numabe A., Nagoshi H., Gomi T., Ikeda T., Goto A., Toyo-oka T., Omata M. (1997): Serum N-acetyl-β-D-glucosaminidase activity in a genetic rat model of non-insulin-dependent diabetes mellitus. Hypertens. Res. 20, 193-199
30. Ujhazy E., Dubovicky M., Balonova T., Jansak J., Zeljenkova D. (1994): Teratological. assessment of stobadine after single and repeated administration in mice. J. Appl. Toxicol. 14, 357-363
31. Waters P. J., Flyn M. D., Corrall R. J. M., Pennock C. A. (1992): Increases in plasma lysosomal enzymes in type 1 (insulin-dependent) diabetes mellitus: relationship to diabetic complications and glycaemic control. Diabetologia 35, 991-995
32. Wolf S. P., Jiang Z. Y., Hunt J. V. (1991): Protein glycation and oxidative stress in diabetes mellitus and aging. Free Radic. Biol. Med. 10, 339-352